Angry Buds Corp. – Trademark Portfolio
Entity Type: 03
Angry Buds Corp. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CLARITY PEN and DABS BASEMENT. The owner is based in Suffern, NY.
Suite 103
1 Executive Boulevard
Suffern, NY 10901
Showing of trademarks Trademarks
Trademark Classifications
Angry Buds Corp.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Angry Buds Corp. have?
Angry Buds Corp. has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 3 cancelled.
What trademark classes does Angry Buds Corp. file in?
Angry Buds Corp. files trademarks across 5 Nice Classification classes. The most active classes are Class 34 (Smokers Articles), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 40 (Treatment & Processing). Class 34 covers tobacco; smokers articles; matches.
What are Angry Buds Corp.'s most well-known trademarks?
Angry Buds Corp.'s registered trademark portfolio includes well-known marks such as CLARITY PEN and DABS BASEMENT. These are among 4 currently registered trademarks in the portfolio.
What is Angry Buds Corp.'s trademark registration success rate?
Angry Buds Corp. has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.